Genetic profile and patient-reported outcomes (PROs) in COPD: a systematic review Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017
STARLINER study, disease behaviour assessed by a wide range of parameters including patient-reported outcomes (PRO) results Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2 -agonist (LABA) therapy: results from the UK general practice research database (GPRD) Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009
Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Relative exposure to inhaled steroids (ratio "ICS-to-total asthma therapy"): Concordant data from electronic medical records, claims data and patient-reported outcomes Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2 -agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020
Examination of variations in responder rates in COPD clinical trial outcomes Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013
Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
Health-related quality of life (HRQL) and patient-reported outcomes (PRO) in COPD patients receiving add-on-therapy with EPs® 7630 Source: Annual Congress 2011 - COPD management Year: 2011
Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK) Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – paediatric findings Source: Eur Respir J 2006; 28: Suppl. 50, 480s Year: 2006
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study) Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK) Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016